Surviving Lymphoma: Post-Cancer Fatigue

Fatigue is a lack of energy or weakness that differs from drowsiness. Fatigue will not go away with extra rest because it is usually the result of an underlying medical condition or treatment.

Cancer treatments like chemotherapy and radiation are known causes of fatigue. Because they are harsh on the body, your organs and cells need time to recover. Thus, fatigue makes you want to rest so you body can heal. However, this type of fatigue does not last too long and is perfectly normal.

Fatigue that continues on for a while may be the result of low blood counts leading to anemia. It's also possible that your thyroid was damaged during treatment. The thyroid helps with energy levels, so damage can result in fatigue. These and other causes are easily treatable, so talk to your doctor if you feel tired for an extended period of time post-treatment.

Post-Cancer Fatigue

Fatigue that persists after cancer is in remission and your medical team rules out other treatable causes is called Post-Cancer Fatigue (PCF).

Though there is no known cause for PCF, you shouldn't worry, as it's normal. Your doctor should continue your regular check-ups to ensure everything is ok.

Fatigue can make it hard to function on a day-to-day basis. The best thing to do is to get adequate rest and think about your energy level. Prioritize your daily tasks so you use your energy on the most important ones. "Establish a new normal" by adjusting your schedule to match your energy.

Photo: Pexels

lymphoma roundup

More Articles

More Articles

In T cell lymphoma, T lymphocytes, which are an essential part of the body's immune response, become malignant. T cell lymphomas account for about...

Lymphomatoid Papulosis (LyP) is a rare skin disorder that involves cancerous looking skin lesions. It is more than a skin condition; it is the...

In non-Hodgkin's lymphoma, you have your B-cell lymphomas and you have your T-cell lymphomas.

Why B...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is a relatively rare B-cell subtype of non-Hodgkin'...

T-Cell Lymphoblastic Lymphoma (T-LBL) is a very rare subtype of non-Hodgkin's lymphoma. It tends to develop in...

In general, a diagnosis of T-cell lymphoma denotes a poorer prognosis than a diagnosis of B-cell lymphoma. One of...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

After some of the dust has settled, the thoughts of many new lymphoma patients turn to diet and nutrition. They want to know if, in the past,...

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

In a perfect world, every case of cancer would respond to, and be cured by first-line therapy. Unfortunately, it is not often the case. This is...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

In 1964, researchers at the National Cancer Institute developed the first combination chemotherapy that cured a...

CHOP chemotherapy is one of the most common chemotherapy regimens for treating Non-...